ici 164384 has been researched along with nafoxidine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McDonnell, DP; O'Malley, BW; Vegeto, E | 1 |
Gottardis, MM; Jordan, VC; Satyaswaroop, PG | 1 |
Giambiagi, N; Pasqualini, JR; Sumida, C | 1 |
Collins, DC; Gagliardi, A | 1 |
Halliwell, B; Wiseman, H | 1 |
Wiseman, H | 1 |
Allan, GF; Beekman, JM; O'Malley, BW; Tsai, MJ; Tsai, SY | 1 |
Jeannin, E; Liu, JW; Picard, D | 1 |
1 review(s) available for ici 164384 and nafoxidine
Article | Year |
---|---|
Pharmacodynamic and biological effects of anti-estrogens in different models.
Topics: Animals; Antibodies, Monoclonal; Cell Division; Clomiphene; DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Female; Growth Substances; Humans; Lipoproteins, LDL; Liver; Nafoxidine; Nitromifene; Polyunsaturated Alkamides; Pyrrolidines; Receptors, Estrogen; Receptors, Progesterone; Species Specificity; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus | 1988 |
7 other study(ies) available for ici 164384 and nafoxidine
Article | Year |
---|---|
Identification of a negative regulatory function for steroid receptors.
Topics: beta-Galactosidase; Estradiol; Estrogen Antagonists; Ethyl Methanesulfonate; Genetic Complementation Test; Genetic Vectors; Homeostasis; Humans; Kinetics; Mifepristone; Mutagenesis; Nafoxidine; Plasmids; Polyunsaturated Alkamides; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Recombinant Proteins; Restriction Mapping; Saccharomyces cerevisiae; Transcription, Genetic | 1992 |
Tamoxifen-stimulated growth of human endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Clomiphene; Enclomiphene; Endometrium; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Piperidines; Polyunsaturated Alkamides; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1991 |
Inhibition of angiogenesis by antiestrogens.
Topics: Animals; Chick Embryo; Clomiphene; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Fulvestrant; Heparin; Hydrocortisone; Nafoxidine; Neovascularization, Pathologic; Polyunsaturated Alkamides; Solubility; Tamoxifen | 1993 |
Tamoxifen and related compounds protect against lipid peroxidation in isolated nuclei: relevance to the potential anticarcinogenic benefits of breast cancer prevention and therapy with tamoxifen?
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Cell Nucleus; Estradiol; Estrogen Antagonists; Female; Humans; Lipid Peroxidation; Liver; Male; Nafoxidine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Structure-Activity Relationship; Tamoxifen | 1994 |
The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential.
Topics: Animals; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Brain; Cattle; Estradiol; Ferric Compounds; Lipid Peroxidation; Male; Microsomes, Liver; Nafoxidine; Polyunsaturated Alkamides; Rats; Tamoxifen | 1994 |
Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.
Topics: Animals; Baculoviridae; Base Sequence; Binding Sites; Chymotrypsin; Cold Temperature; DNA; Estradiol; Estrogens; Gene Expression Regulation; Humans; Molecular Sequence Data; Moths; Nafoxidine; Polyunsaturated Alkamides; Protein Conformation; Receptors, Estrogen; Recombinant Proteins; Sodium Fluoride; Tamoxifen; Transcription, Genetic; Transcriptional Activation; Transfection | 1993 |
The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
Topics: Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Indoles; Nafoxidine; Piperidines; Polyunsaturated Alkamides; Receptors, Estrogen; Saccharomyces cerevisiae; Sulfones; Tamoxifen; Two-Hybrid System Techniques | 1999 |